Skip to content

Haemonetics HAE Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

TFX
TeleflexTFX
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
LivaNova logo
LivaNovaLIVN
ICU Medical logo
ICU MedicalICUI
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's software and technology licenses, net?
Haemonetics (HAE) reported software and technology licenses, net of $141.74M in Q1 2026.
How has Haemonetics's software and technology licenses, net changed year-over-year?
Haemonetics's software and technology licenses, net decreased by 13.6% year-over-year, from $164.11M to $141.74M.
What is the long-term trend for Haemonetics's software and technology licenses, net?
Over 5 years (2021 to 2026), Haemonetics's software and technology licenses, net has grown at a 14.9% compound annual growth rate (CAGR), from $70.88M to $141.74M.